InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
12
T+90 hit rate
69%
T+90 mean return
+5.9%
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Sachdev Amit, Director. Director active across 3 companies, notably Vertex Pharmaceuticals INC / MA. Aggregated, 34 filings have been recorded. Split: 0 buy · 12 sells. Total volume traded: €4.5m. History available since 17 May 2021. The latest transaction was filed on 26 February 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations34 total
3,703 shares@ US$479.619.7% of flowCommon StockSEC:0000875320-25-000133:0
2,470 shares@ US$483.286.5% of flowCommon StockSEC:0000875320-25-000113:0
2,139 shares@ US$463.465.4% of flowCommon StockSEC:0000875320-25-000093:0
6,211 shares0Common StockSEC:0000875320-25-000069:0
2,056 shares@ US$467.985.4% of flowCommon StockSEC:0000875320-25-000046:0
8,210 shares0Common StockSEC:0000875320-25-000022:0
4,600 shares0Common StockSEC:0000875320-24-000172:0
32 shares@ US$430.930.1% of flowCommon StockSEC:0000875320-24-000154:0
2,469 shares@ US$431.795.7% of flowCommon StockSEC:0000875320-24-000107:0
3,191 shares@ US$421.777.2% of flowCommon StockSEC:0000875320-24-000091:0
3,498 shares@ US$424.017.9% of flowCommon StockSEC:0000875320-24-000078:0
2,022 shares@ US$422.744.6% of flowCommon StockSEC:0000875320-24-000053:0
5,814 shares0Common StockSEC:0000875320-24-000030:0
35 shares@ US$369.920.1% of flowCommon StockSEC:0000875320-23-000041:0
10,031 shares@ US$350.0018.4% of flowCommon StockSEC:0000899243-23-018109:0
2,468 shares@ US$289.123.9% of flowCommon StockSEC:0001209191-23-013744:0
3,498 shares@ US$292.855.5% of flowCommon StockSEC:0001209191-23-011699:0
2,611 shares@ US$294.334.1% of flowCommon StockSEC:0001209191-23-009226:0
1,672 shares0Common StockSEC:0001209191-23-006973:0
6,000 shares0Common StockSEC:0001140361-22-009264:0
7,368 shares@ US$227.860.0013% mcap54.4% of flowCommon StockSEC:0000899243-22-008121:0
3,497 shares@ US$232.510.0006% mcap26.2% of flowCommon StockSEC:0000899243-22-007214:0
2,491 shares@ US$237.740.0005% mcap19.0% of flowCommon StockSEC:0001209191-22-009242:0
9,800 shares0Common StockSEC:0001209191-22-006788
9,800 shares0Common StockSEC:0001209191-22-006788:0
25 of 34 declarations
About Sachdev Amit
Amit Sachdev is Executive Vice President, Chief Patient Officer, and Director at Vertex Pharmaceuticals Inc., a biopharmaceutical company. In this role, he oversees patient-centered initiatives and contributes to the overall strategy of the company, aiming to improve patient outcomes.
